Company Profile
Auro Laboratories manufactures and sells active pharmaceutical ingredients (APIs), intermediates, and generic formulations in India. It offers antihistamine. Its portfolio also includes muscle relaxant, diuretic, iron deficiency, anti-diabetic, including Metformin HCL, anti-fungal, ulcer, malaria, and inflammatory, iodine supplement, analgesics, antacids, potassium and sodium iodide, and microcrystalline cellulose specialty chemicals comprising guanidine nitrate.
Its portfolio also includes dimethyl amine HCl, 2-ethoxy benzoic acid, and 3,4,5 - trimethoxy benzoic acid. Additionally, it offers intermediates consisting of glibenclamde sulphonamide for use in API glibenclamide.
Its portfolio also includes cis-bramo benzoate and cls-tosylate that are used in API Ketoconazol, 3,4,5 - trimethoxy benzoic acid, 2-ethoxy benzoic acid for use in API sildenafil citrate, and 5-bromo phthalide that is used in API citalopram.
It also exports products to Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain, and the United Kingdom. The company was incorporated in 1989 and is based in Mumbai, India.